| No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
| 1 |
100mcg rhpth(1-84) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 2 |
25mcg rhpth(1-84) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 3 |
50mcg rhpth(1-84) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 4 |
A: pth (1-84) |
- |
- |
- |
- |
[1] 235 |
| 5 |
Acetate |
Acetate |
- |
- |
- |
[40] 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 70, 71, 73, 75, 76, 78, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 235, 265, 288, 298, 299 |
| 6 |
Alfacalcidol |
Alfacalcidol |
D01518 |
[1] VDR |
[4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
[6] 41, 46, 49, 50, 96, 235 |
| 7 |
Amorphous calcium carbonate |
Calcium carbonate |
D00932, D10802 |
- |
- |
[1] 235 |
| 8 |
Betamethasone |
Betamethasone |
D00244, D00972, D01357, D01402, D01637, D02032, D02286 |
[1] NR3C1 |
[1] Neuroactive ligand-receptor interaction |
[6] 2, 46, 65, 90, 96, 235 |
| 9 |
Calcitriol |
Calcitriol |
D00129 |
[1] VDR |
[4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
[8] 37, 46, 49, 66, 96, 158, 235, 326 |
| 10 |
Calcitriol & calcium |
Calcitriol |
D00129 |
[1] VDR |
[4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
[1] 235 |
| 11 |
Calcium |
Calcium |
- |
- |
- |
[24] 6, 13, 19, 46, 49, 51, 65, 68, 75, 79, 84, 93, 94, 95, 96, 97, 214, 215, 222, 224, 235, 265, 298, 299 |
| 12 |
Calcium carbonate |
Calcium carbonate |
D00932, D10802 |
- |
- |
[7] 13, 19, 46, 75, 96, 235, 299 |
| 13 |
Calcium carbonate and alphacalcidol |
Calcium carbonate |
D00932, D10802 |
- |
- |
[1] 235 |
| 14 |
Calcium citrate |
Calcium citrate |
D00933 |
- |
- |
[3] 46, 84, 235 |
| 15 |
Calcium gluconate |
Calcium gluconate |
D00935 |
- |
- |
[3] 214, 215, 235 |
| 16 |
Calcium lactate |
Calcium lactate |
D00936, D02254 |
- |
- |
[1] 235 |
| 17 |
Carbonate |
Carbonate ion |
- |
- |
- |
[10] 2, 13, 17, 19, 46, 75, 96, 127, 235, 299 |
| 18 |
Combination product (natpara) and drug or supplements [disease and drug registry] |
- |
- |
- |
- |
[1] 235 |
| 19 |
Crystalline calcium supplements |
Calcium |
- |
- |
- |
[1] 235 |
| 20 |
Eb612 (ebp05) |
- |
- |
- |
- |
[1] 235 |
| 21 |
Enterabio's oral parathyroid hormone (1-34) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 22 |
Forsteo |
- |
- |
- |
- |
[3] 70, 235, 274 |
| 23 |
Human recombinant parathyroid hormone |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 24 |
Immediate post operative bioassay of parathyroid hormone |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 25 |
Indocyanine green |
- |
- |
- |
- |
[4] 46, 51, 235, 291 |
| 26 |
Inn parathyroid hormone (1-84) human |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 27 |
Magnesium |
Magnesium |
- |
- |
- |
[15] 6, 11, 13, 46, 64, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 |
| 28 |
Natpara |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 29 |
Natpara/natpar |
- |
- |
- |
- |
[1] 235 |
| 30 |
Npsp 558 |
- |
- |
- |
- |
[1] 235 |
| 31 |
Npsp558 |
- |
- |
- |
- |
[1] 235 |
| 32 |
Open-label pth(1-84) |
- |
- |
- |
- |
[1] 235 |
| 33 |
Parathyroid |
- |
- |
- |
- |
[1] 235 |
| 34 |
Parathyroid hormon 1-84 |
- |
- |
- |
- |
[1] 235 |
| 35 |
Parathyroid hormone |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[2] 70, 235 |
| 36 |
Parathyroid hormone (1-84) human recombinant |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 37 |
Parathyroid hormone (rdna) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 38 |
Parathyroideahormon |
- |
- |
- |
- |
[1] 235 |
| 39 |
Phosphate |
Phosphate ion |
- |
- |
- |
[29] 2, 3, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 283, 284, 285, 286, 299 |
| 40 |
Phosphate and betamethasone acetate, 2 ml. |
Betamethasone |
D00244, D00972, D01357, D01402, D01637, D02032, D02286 |
[1] NR3C1 |
[1] Neuroactive ligand-receptor interaction |
[1] 235 |
| 41 |
Potassium |
Potassium |
D08403 |
- |
- |
[9] 46, 66, 67, 98, 115, 167, 179, 215, 235 |
| 42 |
Potassium sparing diuretic |
Potassium |
D08403 |
- |
- |
[1] 235 |
| 43 |
Preotact |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 44 |
Pth 1-34 |
Teriparatide |
D06078 |
[1] PTH1R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[2] 65, 235 |
| 45 |
Pth1-84 in parent study |
- |
- |
- |
- |
[1] 235 |
| 46 |
Rcombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 47 |
Recombinant human parathyroid hormone (1-84) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 48 |
Recombinant human parathyroid hormone [rhpth(1-84)] |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 49 |
Rhpth |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[3] 70, 235, 326 |
| 50 |
Rhpth(1-84) |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 51 |
Saline 0.9% nacl |
- |
- |
- |
- |
[1] 235 |
| 52 |
Sevelamer |
Sevelamer |
D01983, D06642, D08512 |
- |
- |
[1] 235 |
| 53 |
Sodium citrate |
Sodium citrate |
D01781, D05855 |
- |
- |
[3] 214, 215, 235 |
| 54 |
Sub21634 |
- |
- |
- |
- |
[1] 235 |
| 55 |
Synthetic human parathyroid hormone 1-34 |
Parathyroid hormone |
D05364 |
[2] PTH1R, PTH2R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[1] 235 |
| 56 |
Teriparatide |
Teriparatide |
D06078 |
[1] PTH1R |
[3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
[6] 46, 68, 70, 71, 235, 274 |
| 57 |
Thiazide |
- |
- |
- |
- |
[1] 235 |
| 58 |
Thymus/parathyroid transplantation |
- |
- |
- |
- |
[2] 65, 235 |
| 59 |
Vitamin d |
Vitamin d |
- |
- |
- |
[18] 13, 19, 41, 46, 49, 50, 68, 93, 95, 96, 98, 179, 222, 228, 235, 274, 298, 299 |